A quantitative method for the specific assessment of caspase-6 activity in cell culture
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
A quantitative method for the specific assessment of caspase-6 activity in cell culture. / Ehrnhoefer, Dagmar E; Skotte, Niels H; Savill, Jane; Nguyen, Yen T N; Ladha, Safia; Cao, Li-Ping; Dullaghan, Edie; Hayden, Michael R.
In: PLOS ONE, Vol. 6, No. 11, 2011, p. e27680.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A quantitative method for the specific assessment of caspase-6 activity in cell culture
AU - Ehrnhoefer, Dagmar E
AU - Skotte, Niels H
AU - Savill, Jane
AU - Nguyen, Yen T N
AU - Ladha, Safia
AU - Cao, Li-Ping
AU - Dullaghan, Edie
AU - Hayden, Michael R
PY - 2011
Y1 - 2011
N2 - Aberrant activation of caspase-6 has recently emerged as a major contributor to the pathogeneses of neurodegenerative disorders such as Alzheimer's and Huntington disease. Commercially available assays to measure caspase-6 activity commonly use the VEID peptide as a substrate. However these methods are not well suited to specifically assess caspase-6 activity in the presence of other, confounding protease activities, as often encountered in cell and tissue samples. Here we report the development of a method that overcomes this limitation by using a protein substrate, lamin A, which is highly specific for caspase-6 cleavage at amino acid 230. Using a neo-epitope antibody against cleaved lamin A, we developed an electrochemiluminescence-based ELISA assay that is suitable to specifically detect and quantify caspase-6 activity in highly apoptotic cell extracts. The method is more sensitive than VEID-based assays and can be adapted to a high-content imaging platform for high-throughput screening. This method should be useful to screen for and characterize caspase-6 inhibitor compounds and other interventions to decrease intracellular caspase-6 activity for applications in neurodegenerative disorders.
AB - Aberrant activation of caspase-6 has recently emerged as a major contributor to the pathogeneses of neurodegenerative disorders such as Alzheimer's and Huntington disease. Commercially available assays to measure caspase-6 activity commonly use the VEID peptide as a substrate. However these methods are not well suited to specifically assess caspase-6 activity in the presence of other, confounding protease activities, as often encountered in cell and tissue samples. Here we report the development of a method that overcomes this limitation by using a protein substrate, lamin A, which is highly specific for caspase-6 cleavage at amino acid 230. Using a neo-epitope antibody against cleaved lamin A, we developed an electrochemiluminescence-based ELISA assay that is suitable to specifically detect and quantify caspase-6 activity in highly apoptotic cell extracts. The method is more sensitive than VEID-based assays and can be adapted to a high-content imaging platform for high-throughput screening. This method should be useful to screen for and characterize caspase-6 inhibitor compounds and other interventions to decrease intracellular caspase-6 activity for applications in neurodegenerative disorders.
KW - Amino Acid Sequence
KW - Animals
KW - COS Cells
KW - Caspase 6
KW - Cell Culture Techniques
KW - Cell Extracts
KW - Cercopithecus aethiops
KW - Enzyme Assays
KW - Enzyme-Linked Immunosorbent Assay
KW - Fluorescent Antibody Technique
KW - Humans
KW - Kinetics
KW - Lamins
KW - Luminescence
KW - Mice
KW - Molecular Sequence Data
KW - Neurons
KW - Peptides
KW - Substrate Specificity
U2 - 10.1371/journal.pone.0027680
DO - 10.1371/journal.pone.0027680
M3 - Journal article
C2 - 22140457
VL - 6
SP - e27680
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 11
ER -
ID: 153451326